FDA and industry puzzle over drug-name fixes

Article

FDA and industry hold public meeting on the issue of drug names and drug errors.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Pharmacists Can Help Manage Therapies for Hyperkalemia

Pharmacists Can Help Manage Therapies for Hyperkalemia

Ashley Gallagher
September 18th 2025
Article
The Complex Issues, Opportunities for Pharmacists in Addressing Medication Adherence

The Complex Issues, Opportunities for Pharmacists in Addressing Medication Adherence

Brian Nowosielski;Andrew Maiorini, PharmD, FAHM
September 18th 2025
Podcast
Site Logo

Evidence-Based Hyperkalemia Management: Translating Guidelines Into Pharmacy Practice

September 18th 2025
Article
Dispensing Leadership: The Dominoes Are Falling in Community Pharmacy

Dispensing Leadership: The Dominoes Are Falling in Community Pharmacy

Brian Nowosielski;Shawn Bjorndal, PharmD, RPh;Jesse McCullough, PharmD
September 18th 2025
Podcast
FDA Approves Denosumab-Kyqq as Biosimilar for Prolia, Xgeva

FDA Approves Denosumab-Kyqq as Biosimilar for Prolia, Xgeva

Ashley Gallagher
September 18th 2025
Article
Q&A: Using Data, Addressing Patient Barriers Can Effectively Improve Medication Adherence

Q&A: Using Data, Addressing Patient Barriers Can Effectively Improve Medication Adherence

Brian Nowosielski;Andrew Maiorini, PharmD, FAHM
September 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.